ADICET BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.45 USD | -2.03% |
|
-2.68% | -23.28% |
Chart calendar Adicet Bio, Inc.
72b0403df8831587c0961608e256754b.P1jVbvSDVr-zOJBjAz9ptxRng_WDrFW9tYr4qPgNbRs.Ug-9Q5fNOvzAQqI0NA8T8SIwupjzgRfxweCd2qtvHk9mFKMBha4C_fJb_w~aa4f4ee08753085f06f0486bb71346a4
Upcoming events on Adicet Bio, Inc.
Past events on Adicet Bio, Inc.
| 2024-05-14 04:01 pm | Q1 2024 Earnings Release |
| 2024-05-14 01:30 pm | Citizens JMP Life Sciences Conference |
| 2024-05-10 05:00 pm | American Society of Gene & Cell Therapy Meeting |
| 2024-04-15 03:00 pm | CG Horizons in Oncology Virtual Conference - Panel |
| 2024-03-26 10:30 am | H.C. Wainwright Cell Therapy Virtual Conference |
| 2024-03-19 04:10 pm | Q4 2023 Earnings Release |
| 2024-02-08 03:00 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-04 08:00 am | Business Update Call |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Poster Number 3478 |
| 2023-11-14 12:00 pm | Jefferies London Healthcare Conference |
| 2023-11-08 04:10 pm | Q3 2023 Earnings Release |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 246 |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 684 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 265 |
| 2023-10-14 03:30 pm | AACR-NCI-EORTC International Conference - Poster Number: C117 |
| 2023-08-09 04:15 pm | Q2 2023 Earnings Release |
| 2023-08-09 01:00 pm | Canaccord Genuity Growth Conference |
| 2023-06-26 04:30 pm | ADI-001 Phase 1 Study Results Call |
| 2023-06-08 10:30 am | Jefferies Global Healthcare Conference |
| 2023-06-01 05:00 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 17,9 12,5 43.26% | 9,73 8,33 16.77% | 25,0 35,4 -29.4% | 0,00 0,71 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -39,2 -49,4 20.64% | -61,4 -59,6 -3.1% | -72,6 -51,8 -40.05% | -152 -152 0.03% | -128 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -39,5 -50,3 21.56% | -62,1 -59,8 -3.89% | -69,8 -61,6 -13.21% | -143 -144 0.65% | -119 |
|
Net income Million USD | Released Forecast Spread | -36,7 -47,7 23.06% | -62,0 -59,7 -3.85% | -69,8 -61,7 -13.19% | -143 -143 0.39% | -119 |
|
EPS USD | Released Forecast Spread | -5,01 -4,53 -10.6% | -2,00 -1,89 -5.75% | -1,70 -1,52 -11.96% | -3,31 -3,35 1.27% | -1,47 |
| Announcement Date | 11/03/21 | 15/03/22 | 15/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 25,0 13,7 82.53% | 0,00 1,04 - | 0,00 0,28 - | 0,00 13,0 - | 0,00 4,42 - | 0,00 12,7 - | 0,00 1,11 - | 0,00 0,71 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 4,71 -7,67 161.33% | -22,7 -19,3 -17.77% | -23,0 -22,7 -1.3% | -31,6 -12,2 -159.15% | -33,3 -24,8 -34.56% | -34,9 -17,8 -96.52% | -52,3 -34,4 -51.94% | -31,6 -31,6 0.13% | -30,9 -30,2 -2.17% | -31,8 | -32,4 | -33,2 | -34,4 | -35,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 4,62 -7,24 163.82% | -22,5 -18,7 -20.74% | -22,0 -22,0 0.24% | -29,9 -21,9 -36.32% | -30,9 -23,9 -29.14% | -32,4 -16,4 -98.15% | -49,9 -33,1 -50.88% | -29,5 -30,4 3.06% | -28,0 -28,8 2.68% | -29,6 | -30,4 | -31,3 | -34,0 | -34,7 |
|
Net income Million USD | Released Forecast Spread | 4,62 -7,24 163.82% | -22,5 -18,7 -20.74% | -22,0 -22,2 1.1% | -29,9 -21,9 -36.32% | -30,9 -23,9 -29.14% | -32,4 -16,2 -99.67% | -49,9 -32,8 -52.03% | -29,5 -30,0 1.85% | -28,0 -28,8 2.68% | -29,6 | -30,4 | -31,3 | -34,0 | -34,7 |
|
EPS USD | Released Forecast Spread | 0,10 -0,20 150.85% | -0,56 -0,46 -20.86% | -0,53 -0,53 0.15% | -0,72 -0,53 -35.99% | -0,72 -0,57 -27.28% | -0,75 -0,43 -76.24% | -1,16 -0,76 -51.65% | -0,69 -0,70 1.25% | -0,35 -0,39 11.17% | -0,36 | -0,37 | -0,38 | -0,38 | -0,33 |
| Announcement Date | 12/05/22 | 10/08/22 | 08/11/22 | 15/03/23 | 09/05/23 | 09/08/23 | 08/11/23 | 19/03/24 | 14/05/24 | - | - | - | - | - |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Adicet Bio, Inc.
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACET Stock
- Calendar Adicet Bio, Inc.
